Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Should You Buy?

Fresenius SE & Co. (OTCMKTS:FSNUY)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $11.37, but opened at $11.84. Fresenius SE & Co. shares last traded at $11.2950, with a volume of 11,915 shares changing hands.

Analyst Ratings Changes

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy”.

Fresenius SE & Co. Trading Up 2.5%

The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The company has a fifty day moving average of $11.41 and a two-hundred day moving average of $13.10. The stock has a market capitalization of $26.40 billion, a price-to-earnings ratio of 15.63 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUY) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The firm had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. On average, research analysts expect that Fresenius SE & Co. will post 1.03 EPS for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.